Tezspire 210 MG/1.91 ML syring 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FC96C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,062
Award facts
- Contract value 100% obligated
- $14,061.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $14,061.54 for the supply of Tezspire 210 mg/1.91 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 1, 2025. The award was issued on September 10, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp leverages its prime IDC to provide medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. Tezspire, a biologic medication used in the treatment of moderate to severe eosinophilic asthma, represents the type of specialized pharmaceutical product the contractor supplies through its extensive portfolio of delivery orders with the DLA Medical Supply Chain. The DLA's procurement strategy for pharmaceuticals through prime vendor contracts like this one ensures reliable access to critical medications needed by the Defense Health Agency and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FC96C?
SPE2DB25FC96C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FC96C worth?
The government has obligated $14,062 on SPE2DB25FC96C.
Is contract SPE2DB25FC96C an order under another contract?
Yes. SPE2DB25FC96C is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC96C competed?
The extent of competition for SPE2DB25FC96C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award